(EUNY) iShares Emerging Market - Ratings and Ratios
Emerging, Market, Equities, Dividend, Focus
Description: EUNY iShares Emerging Market
The iShares Emerging Market Dividend UCITS ETF (EUNY) is a German-originated exchange-traded fund that tracks the Morningstar Emerging Markets Dividend Yield Focus Index. This index is designed to capture the performance of dividend-paying stocks in emerging markets.
By investing in EUNY, youre essentially gaining exposure to a diversified portfolio of emerging market equities that have a history of paying consistent dividends. The funds underlying index is constructed to emphasize stocks with high dividend yields, potentially providing a regular income stream for investors.
From a technical standpoint, EUNYs price action has been relatively stable, with its short-term and long-term moving averages indicating a slight uptrend. The current price is near its 52-week high, suggesting a strong performance over the past year. The Average True Range (ATR) indicates a relatively low volatility, which may appeal to risk-averse investors.
Fundamentally, EUNY has a respectable Assets Under Management (AUM) of approximately 565.86 million EUR, indicating a moderate level of investor interest. As the fund is focused on dividend-paying stocks in emerging markets, its likely to be influenced by macroeconomic trends, interest rates, and the overall health of the global economy.
Forecasting EUNYs future performance involves analyzing both its technical and fundamental data. Given its current price is near the 52-week high and the SMA20 is above the SMA50, a short-term bullish trend is indicated. However, the ATR suggests that the volatility is relatively low, which might limit the upside potential. Considering the AUM and the overall trend in emerging markets, a potential price target for EUNY could be around 14.50, representing a 6% increase from its current price. Conversely, a decline in emerging market sentiment or a rise in global interest rates could lead to a pullback, potentially testing the 12.50 level.
EUNY ETF Overview
Market Cap in USD | 664m |
Category | Global Emerging Markets Equity |
TER | 0.65% |
IPO / Inception | 2011-11-25 |
EUNY ETF Ratings
Growth Rating | 59.9% |
Fundamental | - |
Dividend Rating | 66.3% |
Return 12m vs S&P 500 | -2.31% |
Analyst Rating | - |
EUNY Dividends
Dividend Yield 12m | 7.23% |
Yield on Cost 5y | 10.55% |
Annual Growth 5y | 3.53% |
Payout Consistency | 93.4% |
Payout Ratio | % |
EUNY Growth Ratios
Growth Correlation 3m | 93.6% |
Growth Correlation 12m | 60.6% |
Growth Correlation 5y | 36.3% |
CAGR 5y | 12.05% |
CAGR/Max DD 3y | 0.77 |
CAGR/Mean DD 3y | 4.52 |
Sharpe Ratio 12m | 0.88 |
Alpha | -0.62 |
Beta | 0.721 |
Volatility | 12.17% |
Current Volume | 40k |
Average Volume 20d | 68.5k |
Stop Loss | 13.8 (-3.2%) |
Signal | 0.53 |
What is the price of EUNY shares?
Over the past week, the price has changed by -0.04%, over one month by +2.80%, over three months by +5.49% and over the past year by +15.52%.
Is iShares Emerging Market a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EUNY is around 16.86 EUR . This means that EUNY is currently undervalued and has a potential upside of +18.32% (Margin of Safety).
Is EUNY a buy, sell or hold?
What are the forecasts/targets for the EUNY price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 18.8 | 32.1% |
EUNY Fundamental Data Overview
Market Cap EUR = 565.9m (565.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 565.9m EUR (565.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 565.9m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 565.9m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(565.9m)/V(0.0) * Re(8.67%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)